The aim of the study was to evaluate mortality and rehospitalizations after a first episode of Community Acquired Pneumonia (CAP) and to assess preliminary impact data of 13-valent pneumococcal conjugate vaccination (PCV 13) in the elderly. Preliminary analysis showed that PCV13 vaccination plays an important role in reducing re-hospitalization and mortality in elderly subjects. Long-term studies to confirm potential benefit are needed.
Vaccination status impact on mortality and hospital re-admission for CAP in elderly: a regional italian experience
BALDO, VINCENZO;COCCHIO, SILVIA;FURLAN, PATRIZIA;BERTONCELLO, CHIARA;BALDOVIN, TATJANA
2016
Abstract
The aim of the study was to evaluate mortality and rehospitalizations after a first episode of Community Acquired Pneumonia (CAP) and to assess preliminary impact data of 13-valent pneumococcal conjugate vaccination (PCV 13) in the elderly. Preliminary analysis showed that PCV13 vaccination plays an important role in reducing re-hospitalization and mortality in elderly subjects. Long-term studies to confirm potential benefit are needed.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
